Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dianne Poh"'
Autor:
Naoto Takahashi, V. S. Nadarajan, Yijun Ruan, Anbupalam Thalamuthu, Wing-Kin Sung, Xing Yi Woo, Hae Tha Mya, Sheila Soh, Xiaoan Ruan, Wen Chun Juan, Kazutoshi Isobe, Markus M. Nöthen, Wan-Teck Lim, John W.J. Huang, Hein Than, Yao Fei, L.Y. Yang, Chia-Tien Chang, Dianne Poh, Noan-Minh Chau, Axel M. Hillmer, Liang Piu Koh, Ai Leen Ang, Gee Fung How, Mei-Kim Ang, Yeow Tee Goh, Lay Cheng Lim, Tan Min Chin, Daniel Shao-Weng Tan, Wee Joo Chng, Balram Chowbay, Audrey S.M. Teo, Hiroyuki Mano, Ju Ee Seet, Niranjan Nagarajan, Quan Sing Ng, Shenli Zhang, Pramila N. Ariyaratne, Atif Shahab, Wan Ting Poh, Manabu Soda, Patrick Tan, Yasushi Yatabe, Kenichi Sawada, Vikrant Kumar, Ross A. Soo, Tien Yin Wong, Valere Cacheux-Rataboul, Charles Chuah, Eng Huat Tan, John Carson Allen, King Pan Ng, Wah Heng Lee, S. Tiong Ong, Tun Kiat Ko
Publikováno v:
Nature medicine. 18(4)
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small-cell lung cancer (EGFR NSCLC). However, th
Autor:
Yao Fei, Axel M. Hillmer, Yeow Tee Goh, Shenli Zhang, John Carson Allen, Pramila N. Ariyaratne, Kazutoshi Isobe, King Pan Ng, Markus M. Nöthen, Charles Chuah, Wah Heng Lee, Hiroyuki Mano, V. S. Nadarajan, Yijun Ruan, Eng Huat Tan, Vikrant Kumar, Niranjan Nagarajan, Noan-Minh Chau, Xiaoan Ruan, Atif Shahab, Manabu Soda, Yasushi Yatabe, S. Tiong Ong, Mei-Kim Ang, Wing-Kin Sung, Daniel Shao-Weng Tan, Wee Joo Chng, Dianne Poh, John W.J. Huang, Audrey S.M. Teo, Sheila Soh, Xing Yi Woo, Tien Yin Wong, Patrick Tan, Tan Min Chin, Kenichi Sawada, Tun-Kiat Ko, Lay Cheng Lim, Liang Piu Koh, Wan Ting Poh, Ross A. Soo, Ju Ee Seet, Wan-Teck Lim, Hein Than, Quan Sing Ng, Wen Chun Juan, L.Y. Yang, Naoto Takahashi, Anbupalam Thalamuthu, Valere Cacheux-Rataboul
Publikováno v:
Cancer Research. 72:1911-1911
The use of tyrosine kinase inhibitors (TKI) to target oncogenic kinases has led to remarkable responses in patients with chronic myeloid leukemia (CML) and EGFR-mutated non-small cell lung cancer (EGFR NSCLC). However, a significant subset of patient